Breast cancer: evaluation of response to neoadjuvant chemotherapy with 3.0-T MR imaging. - Wikidata - wikimedia - TriplyDB

Breast cancer: evaluation of response to neoadjuvant chemotherapy with 3.0-T MR imaging.

Breast cancer: evaluation of response to neoadjuvant chemotherapy with 3.0-T MR imaging.

http://www.wikidata.org/entity/Q35560975

about

Novel nano-sized MR contrast agent mediates strong tumor contrast enhancement in an oncogene-driven breast cancer model The role of magnetic resonance imaging in assessing residual disease and pathologic complete response in breast cancer patients receiving neoadjuvant chemotherapy: a systematic review Breast DCE-MRI Kinetic Heterogeneity Tumor Markers: Preliminary Associations With Neoadjuvant Chemotherapy Response.Do MRI and mammography reliably identify candidates for breast conservation after neoadjuvant chemotherapy?Identification of intrinsic imaging phenotypes for breast cancer tumors: preliminary associations with gene expression profiles.Analysis of complete response by MRI following neoadjuvant chemotherapy predicts pathological tumor responses differently for molecular subtypes of breast cancer.Dynamic contrast-enhanced MR imaging in a phase Ⅱ study on neoadjuvant chemotherapy combining Rh-endostatin with docetaxel and epirubicin for locally advanced breast cancer Effect of taxane-based neoadjuvant chemotherapy on fibroglandular tissue volume and percent breast density in the contralateral normal breast evaluated by 3T MR.Impact of factors affecting the residual tumor size diagnosed by MRI following neoadjuvant chemotherapy in comparison to pathology.Can diffusion-weighted MR imaging and contrast-enhanced MR imaging precisely evaluate and predict pathological response to neoadjuvant chemotherapy in patients with breast cancer?Evaluation with 3.0-T MR imaging: predicting the pathological response of triple-negative breast cancer treated with anthracycline and taxane neoadjuvant chemotherapy.Prospective trial of breast MRI versus 2D and 3D ultrasound for evaluation of response to neoadjuvant chemotherapy.MR and mammographic imaging features of HER2-positive breast cancers according to hormone receptor status: a retrospective comparative study.Surgical issues in patients with breast cancer receiving neoadjuvant chemotherapy.Trends and controversies in multidisciplinary care of the patient with breast cancer.Clinical application of magnetic resonance imaging in management of breast cancer patients receiving neoadjuvant chemotherapy.MRI and Prediction of Pathologic Complete Response in the Breast and Axilla after Neoadjuvant Chemotherapy for Breast Cancer.Performance of Mid-Treatment Breast Ultrasound and Axillary Ultrasound in Predicting Response to Neoadjuvant Chemotherapy by Breast Cancer Subtype.

P2860

Q34306808-2E6C0965-49D3-41FB-9E35-B7C1C464D54C Q34566213-FDEA14B3-9295-4F88-9B88-A3819E9112D4 Q35804283-29D92195-97ED-400F-8323-F567593EAA28 Q35878696-BAD49F4F-924C-48E7-ADF1-63BA44D595F8 Q36041569-742AF98D-D780-4B2A-8D16-97FB13D255F5 Q36475463-E89FD0B1-3F48-41B9-A543-FAE534CE155F Q36540092-C2E00575-5147-4012-97F1-260BEC0E1B11 Q37337157-46766F97-7119-42AF-82F3-47C1297FC719 Q37734922-98B6A75D-D993-483E-9261-3A59F357F1A2 Q38000076-F778074C-4538-4AEB-B1A9-94C34B5FB3FB Q38250247-43DAEA4C-360F-474F-B9AB-251A425EF6FC Q38318588-4668FBDD-4672-47D1-8E65-4824C373D124 Q38409734-190A3DEA-EF05-4C9E-B307-BAAA10937278 Q38409756-07CD5FCD-E39C-41A1-87F7-8CB13293410D Q39119467-A1906EDD-D99F-4AB1-870D-F6CA95796513 Q44491240-FB72603A-A2A1-47B5-BF4C-39215CFCB176 Q50052437-6751378E-7A27-4B57-B3D8-D46D7D8CBA69 Q55003756-6BFC8FA1-E2E2-4C1F-B68B-2CA4F2198D62

P2860

Breast cancer: evaluation of response to neoadjuvant chemotherapy with 3.0-T MR imaging.

http://www.wikidata.org/entity/Q35560975

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Breast cancer: evaluation of response to neoadjuvant chemotherapy with 3.0-T MR imaging.

@ast

Breast cancer: evaluation of response to neoadjuvant chemotherapy with 3.0-T MR imaging.

@en

type

label

Breast cancer: evaluation of response to neoadjuvant chemotherapy with 3.0-T MR imaging.

@ast

Breast cancer: evaluation of response to neoadjuvant chemotherapy with 3.0-T MR imaging.

@en

prefLabel

Breast cancer: evaluation of response to neoadjuvant chemotherapy with 3.0-T MR imaging.

@ast

Breast cancer: evaluation of response to neoadjuvant chemotherapy with 3.0-T MR imaging.

@en

P1433

Q35560975-98EA26D5-4FFB-40BE-A534-85E88ACAF976

P1476

Q35560975-0ECC47A9-F73B-4EED-B201-D07D0E43A146

P2093

Q35560975-011751C4-3E3A-4A58-992E-797C18399C05

Q35560975-02A51261-8177-4214-8DA1-0948FDC67E5A

Q35560975-0E71E9D2-FD64-4D4E-9430-BA99EA54B66D

Q35560975-254EB3B4-8EE9-4369-BE56-21111DE95E56

Q35560975-656A31F3-06D0-4EFC-AAE5-424F0CA8D344

Q35560975-70753094-5DDA-477B-965F-2FDFA9A42B0E

Q35560975-9466CFE7-E92D-4F82-9B79-CBBF880A73C3

Q35560975-9B990697-AF5B-41FA-8C02-6B95455879DB

Q35560975-A471C33C-19FE-428C-B894-DD8C43630920

Q35560975-B3B5FDB0-4550-4F58-AB62-B3C25E11B3ED

P2860

Q35560975-272CECC4-1B43-4138-A3E8-835CDB8375F9

Q35560975-3D1B4A17-E3E9-4523-8C17-95FD79CCCAB3

Q35560975-4BBEFAF5-ADCB-482F-BC17-EA5CD2B20D6D

Q35560975-4DCA4DAC-E850-4BD4-B239-7AE22ADAAD6B

Q35560975-54CC236F-400C-481B-9111-0C3C0B236951

Q35560975-57A7D075-470C-4A6D-8376-DE98C015E672

Q35560975-5D65ECBA-7B88-4DF9-A039-571D4C67724F

Q35560975-5D984843-8292-4A8B-AB17-8FF586505E29

Q35560975-6611E8EE-4F3A-4A74-8BE6-C02612A4C672

Q35560975-804D29CB-36D8-4D0A-B40C-6A80F8C2D94A

P304

Q35560975-CE450612-D6D3-4C1F-916A-C9CEE13B62BC

P31

Q35560975-31ECF353-5BDF-4E60-A2ED-706A74A06500

P356

Q35560975-ECF09C88-D677-417B-BDAB-C68535D0985C

P407

Q35560975-D416E5F1-E105-48B0-A207-63C09F5D9F88

P433

Q35560975-D05C3C55-FAD1-40C3-8EB7-8FDADB0E2378

P478

Q35560975-E23D9B08-10D7-45B4-9A51-6D6D19DA6E9B

P577

Q35560975-22117BA2-9DA6-41AA-BCDF-93ED260029AA

P5875

Q35560975-481283A4-96D0-4DD3-91E8-6894006B7EB0

P698

Q35560975-16B00278-2B04-41FB-9AB5-BF6DA49A29B3

P921

Q35560975-B7225AF8-CDD5-494C-A713-7EA3127E56C4

P932

Q35560975-3594F1A5-A61C-42A8-A26E-DBE83E13FF61

P356

RADIOL.11110814

P1433

P1476

Breast cancer: evaluation of response to neoadjuvant chemotherapy with 3.0-T MR imaging.

@en

P2093

Aida Kuzucan

http://www.w3.org/2001/XMLSchema#string

David J B Hsiang

http://www.w3.org/2001/XMLSchema#string

Hon J Yu

http://www.w3.org/2001/XMLSchema#string

Jeon-Hor Chen

http://www.w3.org/2001/XMLSchema#string

John A Butler

http://www.w3.org/2001/XMLSchema#string

Karen T Lane

http://www.w3.org/2001/XMLSchema#string

Min-Ying Su

http://www.w3.org/2001/XMLSchema#string

Muqing Lin

http://www.w3.org/2001/XMLSchema#string

Orhan Nalcioglu

http://www.w3.org/2001/XMLSchema#string

Philip M Carpenter

http://www.w3.org/2001/XMLSchema#string

P2860

High field human imaging.

Relaxation times of breast tissue at 1.5T and 3T measured using IDEAL.

Neoadjuvant chemotherapy for operable breast cancer.

Neoadjuvant chemotherapy for breast carcinoma: multidisciplinary considerations of benefits and risks.

Contrast-enhanced MR imaging of the breast at 3.0 and 1.5 T in the same patients: initial experience.

A review of normal tissue hydrogen NMR relaxation times and relaxation mechanisms from 1-100 MHz: dependence on tissue type, NMR frequency, temperature, species, excision, and age.

Pathological complete response and residual DCIS following neoadjuvant chemotherapy for breast carcinoma

Using MRI to plan breast-conserving surgery following neoadjuvant chemotherapy for early breast cancer.

Magnetic resonance imaging of breast lesions--a pathologic correlation.

Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: new perspectives 2006.

P304

735-743

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1148/RADIOL.11110814

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

261

http://www.w3.org/2001/XMLSchema#string

P577

2011-08-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51606413

http://www.w3.org/2001/XMLSchema#string

P698

21878615

http://www.w3.org/2001/XMLSchema#string

P921

P932

3219909

http://www.w3.org/2001/XMLSchema#string